Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06544707
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
A Study Designed to Evaluate Tear Production
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 3b Open-Label Study Designed to Evaluate Tear Production Stimulated by 0003 AR-15512
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate tear production following acute administration of AR-15512 ophthalmic solution 0003 0003 AR-15512 in subjects with dry eye disease DED
Detailed Description:
Qualified subjects will attend a single visit
This is a Phase 3b study
This is a Phase 3b study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None